HELP     Sign In
Search

Relevance to Autism

This gene has been associated with syndromic autism, where a subpopulation of individuals with a given syndrome develop autism. In particular, genetic association exists between autism and tuberous sclerosis (and hence the TSC1 and TSC2 genes as well).

Molecular Function

This gene encodes a growth inhibitory protein thought to play a role in the stabilization of tuberin and has been implicated as a tumor supressor.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Autism and tuberous sclerosis.
Tuberous sclerosis-1
ASD
Negative Association
Lack of association of rare functional variants in TSC1/TSC2 genes with autism spectrum disorder.
ASD
Support
Genetic and Phenotype Analysis of a Chinese Cohort of Infants and Children With Epilepsy
Epilepsy/seizures
Support
Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders.
ASD
Support
ASD
DD, ID
Support
Neurological Diseases With Autism Spectrum Disorder: Role of ASD Risk Genes.
ASD
Tuberous sclerosis complex
Support
Genetic care in geographically isolated small island communities: 8 years of experience in the Dutch Caribbean
Epilepsy/seizures
Support
Diagnostic exome sequencing of syndromic epilepsy patients in clinical practice.
Epilepsy/seizures, ID
Support
Autism spectrum disorder and comorbid neurodevelopmental disorders (ASD-NDDs): Clinical and genetic profile of a pediatric cohort
ASD
Epilepsy/seizures
Support
Tuberous sclerosis complex, ASD
Support
Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
Focal cortical dysplasia
Support
Tuberous sclerosis 1
Support
Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder
ASD
Support
Integrating de novo and inherited variants in 42
ASD
Support
Massively parallel sequencing of patients with intellectual disability, congenital anomalies and/or autism spectrum disorders with a targeted gene ...
DD, ID, ASD
MCA
Support
Support
Genome sequencing of 320 Chinese children with epilepsy: a clinical and molecular study
Epilepsy/seizures
Support
Synaptic hyperexcitability of cytomegalic pyramidal neurons contributes to epileptogenesis in tuberous sclerosis complex
Tuberous sclerosis-1
Epilepsy/seizures
Support
Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations.
ASD
Support
Tuberous sclerosis-1
ASD
Support
Sensitive period for rescuing parvalbumin interneurons connectivity and social behavior deficits caused by TSC1 loss
ASD
Support
Tsc1 Haploinsufficiency Leads to Pax2 Dysregulation in the Developing Murine Cerebellum
Support
High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism.
Non-syndromic ASD
Support
DD, ID, epilepsy/seizures
Support
The Clinical and Genetic Features of Co-occurring Epilepsy and Autism Spectrum Disorder in Chinese Children.
ASD, epilepsy/seizures
Highly Cited
Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.
Highly Cited
Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling.
Recent Recommendation
Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex.
Recent Recommendation
Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures.
Recent Recommendation
Tuberous sclerosis complex proteins control axon formation.
Recent Recommendation
Cognitive deficits in Tsc1 mice in the absence of cerebral lesions and seizures.
Recent Recommendation
Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells.
Recent recommendation
TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling.
Tuberous sclerosis-1
Recent Recommendation
Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.
Recent Recommendation
Regionally specific TSC1 and TSC2 gene expression in tuberous sclerosis complex.
Recent Recommendation
Neuroepileptic correlates of autistic symptomatology in tuberous sclerosis.

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN255R001 
  
  
  
  
  
  
 GEN255R002 
 missense_variant 
 c.2199A>G 
 p.Met1067Leu 
 Unknown 
  
 Simplex 
 GEN255R003 
 missense_variant 
 c.3103G>A 
 p.Gly1035Ser 
 Unknown 
  
 Simplex 
 GEN255R004 
 missense_variant 
 c.2285A>G 
 p.Asn762Ser 
 Unknown 
  
 Simplex 
 GEN255R005 
 missense_variant 
 c.2194C>T 
 p.His732Tyr 
 Familial (1 case); unknown (1 case) 
 Maternal (1 case) 
 Simplex 
 GEN255R006 
 missense_variant 
 c.1760A>G 
 p.Lys587Arg 
 Familial (4 cases); unknown (3 cases) 
 Maternal (3 cases); paternal (1 cases) 
 Simplex 
 GEN255R007 
 missense_variant 
 c.1342C>T 
 p.Pro448Ser 
 Unknown 
  
 Simplex 
 GEN255R008 
 missense_variant 
 c.1208C>T 
 p.Ser403Leu 
 Familial (1 case); unknown (1 case) 
 Paternal (1 case) 
 Simplex 
 GEN255R009 
 missense_variant 
 c.1079C>A 
 p.Thr360Asn 
 Familial (2 cases); unknown (1 case) 
 Paternal (2 cases) 
 Simplex 
 GEN255R010 
 missense_variant 
 c.1006C>T 
 p.Arg336Trp 
 Familial 
 Paternal 
 Simplex 
 GEN255R011 
 synonymous_variant 
 c.201A>G 
 p.Pro67= 
  
  
 Multiplex 
 GEN255R012 
 intron_variant 
 c.210+18A>G 
  
  
  
 Multiplex 
 GEN255R013 
 missense_variant 
 c.346T>G 
 p.Leu116Val 
  
  
 Multiplex 
 GEN255R014 
 missense_variant 
 c.692C>T 
 p.Pro231Leu 
  
  
 Multiplex 
 GEN255R015 
 missense_variant 
 c.1006C>T 
 p.Arg336Trp 
  
  
 Multiplex 
 GEN255R016 
 missense_variant 
 c.1178C>T 
 p.Thr393Ile 
  
  
 Multiplex 
 GEN255R017 
 missense_variant 
 c.1342C>T 
 p.Pro448Ser 
  
  
 Multiplex 
 GEN255R018 
 missense_variant 
 c.1580A>G 
 p.Gln527Arg 
  
  
 Multiplex 
 GEN255R019 
 missense_variant 
 c.1960C>G 
 p.Gln654Glu 
  
  
 Multiplex 
 GEN255R020 
 intron_variant 
 c.2392-13T>C 
  
  
  
 Multiplex 
 GEN255R021 
 intron_variant 
 c.2626-3C>T 
  
  
  
 Multiplex 
 GEN255R022 
 missense_variant 
 c.2718A>C 
 p.Gln906His 
  
  
 Multiplex 
 GEN255R023 
 synonymous_variant 
 c.3042C>T 
 p.His1014= 
  
  
 Multiplex 
 GEN255R024 
 missense_variant 
 c.1079C>A 
 p.Thr360Asn 
 Familial 
  
 Simplex 
 GEN255R025 
 missense_variant 
 c.1342C>T 
 p.Pro448Ser 
 Familial 
 Paternal 
 Simplex 
 GEN255R026 
 missense_variant 
 c.556G>T 
 p.Ala186Ser 
 Familial 
 Maternal 
 Multiplex 
 GEN255R027 
 missense_variant 
 c.16A>G 
 p.Asn6Asp 
 Familial 
 Maternal 
  
 GEN255R028 
 missense_variant 
 c.610C>T 
 p.Arg204Cys 
  
  
  
 GEN255R029 
 missense_variant 
 c.64C>T 
 p.Arg22Trp 
  
  
  
 GEN255R030 
 missense_variant 
 c.64C>T 
 p.Arg22Trp 
  
  
  
 GEN255R031 
 missense_variant 
 c.64C>T 
 p.Arg22Trp 
  
  
  
 GEN255R032 
 frameshift_variant 
 c.658del 
 p.Val220SerfsTer4 
 De novo 
  
  
 GEN255R033 
 inframe_deletion 
 c.2506_2509del 
 p.Ser836ThrfsTer12 
 De novo 
  
  
 GEN255R034 
 frameshift_variant 
 c.570_583del 
 p.Leu191ProfsTer22 
 Familial 
 Maternal 
  
 GEN255R035 
 frameshift_variant 
 c.2047_2048insTG 
 p.Pro683LeufsTer42 
 Unknown 
  
  
 GEN255R036 
 frameshift_variant 
 c.1530_1531del 
 p.Asp510GlufsTer24 
 De novo 
  
  
 GEN255R037 
 frameshift_variant 
 c.2559_2563del 
 p.Leu853PhefsTer49 
 Unknown 
  
  
 GEN255R038 
 frameshift_variant 
 c.1888_1891del 
 p.Lys630GlnfsTer22 
 Unknown 
  
  
 GEN255R039 
 frameshift_variant 
 c.1591del 
 p.Val531Ter 
 Unknown 
  
  
 GEN255R040 
 stop_gained 
 c.445C>T 
 p.Gln149Ter 
 Unknown 
  
  
 GEN255R041 
 stop_gained 
 c.2773G>T 
 p.Glu925Ter 
 Unknown 
  
  
 GEN255R042 
 frameshift_variant 
 c.570_583del 
 p.Leu191ProfsTer22 
 Familial 
 Maternal 
  
 GEN255R043 
 frameshift_variant 
 c.2047_2048insTG 
 p.Pro683LeufsTer42 
 Unknown 
  
  
 GEN255R044 
 frameshift_variant 
 c.2509_2512del 
 p.Asn837ValfsTer11 
 Unknown 
  
  
 GEN255R045 
 missense_variant 
 c.2144G>A 
 p.Arg715Gln 
 Unknown 
  
  
 GEN255R046 
 missense_variant 
 c.2722C>T 
 p.Arg908Trp 
 De novo 
  
  
 GEN255R047 
 stop_gained 
 c.2380C>T 
 p.Gln794Ter 
 De novo 
  
  
 GEN255R048 
 frameshift_variant 
 c.1797dup 
 p.Gln600AlafsTer6 
 De novo 
  
  
 GEN255R049 
 missense_variant 
 c.1006C>T 
 p.Arg336Trp 
 De novo 
  
  
 GEN255R050 
 stop_gained 
 c.751G>T 
 p.Glu251Ter 
 De novo 
  
  
 GEN255R051 
 splice_site_variant 
 c.-80-2A>G 
  
 Familial 
 Maternal 
 Multiplex 
 GEN255R052 
 missense_variant 
 c.1816C>T 
 p.His606Tyr 
 Unknown 
  
 Simplex 
 GEN255R053 
 stop_gained 
 c.2074C>T 
 p.Arg692Ter 
 Unknown 
  
 Multiplex 
  et al.  

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
9
Duplication
 1
 
9
Deletion
 1
 
9
Duplication
 1
 
9
Duplication
 1
 
9
Deletion-Duplication
 10
 
9
N/A
 2
 
9
Duplication
 2
 
9
Deletion-Duplication
 9
 

Model Summary

Tsc1 mutant mice showed behavioral changes, such as decreased social approach and novelty and increased grooming and behavioral inflexibility. Activation of RCrusI rescued impaired social approach and novelty behaviors but had no effect on increased grooming or perseveration.

References

Type
Title
Author, Year
Primary
A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.
Additional
A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.
Additional
Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Additional
GABAergic interneuron development and function is modulated by the Tsc1 gene.
Additional
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice.
Additional
Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex.
Additional
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex.
Additional
Temporal and mosaic Tsc1 deletion in the developing thalamus disrupts thalamocortical circuitry, neural function, and behavior.
Additional
Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.
Additional
Cerebellar associative sensory learning defects in five mouse autism models.
Additional
Altered cerebellar connectivity in autism and cerebellar-mediated rescue of autism-related behaviors in mice.
Additional
Sensitive Periods for Cerebellar-Mediated Autistic-like Behaviors.
Additional
Striatal Inhibition of MeCP2 or TSC1 Produces Sociability Deficits and Repetitive Behaviors.
Additional
Sensitive period for rescuing parvalbumin interneurons connectivity and social behavior deficits caused by TSC1 loss

M_TSC1_1_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Targeted disruption of exons 17 and 18 of Tsc1 gene using homologous recombination leading to termination of translation.
Allele Type: Targeted (Knock Out)
Strain of Origin: 129/Sv
Genetic Background: C57BL/6J, BALB/cJ; 129/SvJae
ES Cell Line: J1
Mutant ES Cell Line: Not Specified
Model Source: Not Specified

M_TSC1_2_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Targeted disruption of exons 17 and 18 of Tsc1 gene using homologous recombination leading to termination of translation.
Allele Type: Targeted (Knock Out)
Strain of Origin: 129/Sv
Genetic Background: C57BL/6J, BALB/cJ; 129/SvJae
ES Cell Line: J1
Mutant ES Cell Line: Not Specified
Model Source: Not Specified

M_TSC1_3_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exons 17-18 of the Tsc1 gene using GFAP1-cre, in astrocytes/glia
Allele Type: Conditional loss-of-function
Strain of Origin: Not Specified
Genetic Background: Not Specified
ES Cell Line: Not Specified
Mutant ES Cell Line: Not Specified
Model Source: Not Specified

M_TSC1_4_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exons 17 and 18 of Tsc1 gene using Dlx5/6 enhancer -cre expressed, in interneurons
Allele Type: Conditional loss-of-function
Strain of Origin: Not Specified
Genetic Background: C57/SV129
ES Cell Line: Not Specified
Mutant ES Cell Line: Not Specified
Model Source: Not Specified

M_TSC1_5_CKO_HM_PURKINJEN

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional heterozygous deletion of exons 17 and 18 of Tsc1 gene using L7 cre from Purkinje neurons of the cerebellum
Allele Type: Conditional loss-of-function
Strain of Origin: Not specified
Genetic Background: Not specified
ES Cell Line: Not specified
Mutant ES Cell Line: Not specified
Model Source: Not specified

M_TSC1_5_CKO_HT_PURKINJEN

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exons 17 and 18 of Tsc1 gene using L7 cre from Purkinje neurons of the cerebellum
Allele Type: Conditional loss-of-function
Strain of Origin: Not specified
Genetic Background: Not specified
ES Cell Line: Not specified
Mutant ES Cell Line: Not specified
Model Source: Not specified

M_TSC1_12_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional heterozygous deletion of exons 17 and 18 of Tsc1 gene using Emx-cre, in the neurons and glia of the neocortex, hippocampus and pallium starting E10.5
Allele Type: Conditional loss-of-function
Strain of Origin: Not specified
Genetic Background: Not Specified
ES Cell Line: Not specified
Mutant ES Cell Line: Not specified
Model Source: Not specified

M_TSC1_12_CKO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Conditional heterozygous deletion of exons 17 and 18 of Tsc1 gene using Emx-cre, in the neurons and glia of the neocortex, hippocampus and pallium, E10.5
Allele Type: Conditional loss-of-function
Strain of Origin: Not specified
Genetic Background: Not Specified
ES Cell Line: Not specified
Mutant ES Cell Line: Not specified
Model Source: Not specified

M_TSC1_7_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Targeted disruption of exons 6-8 replaced by IRES-EGFP-pA expression unit resulting in frameshift.
Allele Type: Targeted (Knock Out)
Strain of Origin: Not specified
Genetic Background: C57BL/6J
ES Cell Line: Not specified
Mutant ES Cell Line: Not Specified
Model Source: Not Specified

M_TSC1_8_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exons 17 and 18 of Tsc1 gene using Gbx2-creER, in thalamic cells with tamoxifen administration on E12.5. Thalamic projections were labeled using R26tdTomato
Allele Type: Conditional loss-of-function
Strain of Origin: Not specified
Genetic Background: Not Specified
ES Cell Line: Not specified
Mutant ES Cell Line: Not Specified
Model Source: Not Specified

M_TSC1_9_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exons 17 and 18 of Tsc1 gene using Gbx2-creER, in thalamic cells with tamoxifen administration on E18.5.Thalamic projections were labeled using R26tdTomato
Allele Type: Conditional loss-of-function
Strain of Origin: Not specified
Genetic Background: Not Specified
ES Cell Line: Not specified
Mutant ES Cell Line: Not Specified
Model Source: Not Specified

M_TSC1_10_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exons 17-18 of the Tsc1 gene using CamkII-cre, resulting in the gradual loss of Tsc1 from neurons, glia in the deep cortical layers at the time period during which spinal pruning is believed to take place ( between P20:P29-30)
Allele Type: Conditional loss-of-function
Strain of Origin:
Genetic Background: C57BL/6 * 129SvJae
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_TSC1_11_CKO_HM_PURKINJEN

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exons 17-18 of the Tsc1 gene using L7-cre in Purkinje cells of the cerebellum
Allele Type: Conditional loss-of-function
Strain of Origin:
Genetic Background: C57BL/6J * 129SvJae * BALB/cJ
ES Cell Line:
Mutant ES Cell Line:
Model Source: Jackson Laboratories

M_TSC1_12_KD

Model Type: Genetic
Model Genotype: Wildtype
Mutation: Seven-week-old wildtype C57BL/6 male mice were injected with Tsc1-siRNA (1441941, NM_022887.2), bilaterally in the dorsal striatum using a stereotaxic apparatus, resulting in a reduction of Tsc1 transcript levels to 0.4 fold compared with control siRNA injected mice.
Allele Type: Knockdown
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: Daehan BioLink (Eumsung, Chungbuk, Republic of Korea)

M_TSC1_13_CKO_HM

Model Type: Genetic LOF
Model Genotype: Homozygous
Mutation: Tsc1 conditional-ready floxed mice were crossed to pv-cre mice. in the conditional-ready mice, a floxed neo-tk cassette was inserted into the intron preceding exon 17 and a third loxp site was introduced downstream of exon 18 by homologous recombination. to confirm the time course and specificity of cre expression in pv-cre mice were crossed with rce^gfp reporter mice. (pv-cre; tsc1flox/flox mice)
Allele Type: Conditional knockout
Strain of Origin: 129S4/SvJae
Genetic Background: Not reoprted
ES Cell Line: NA
Mutant ES Cell Line: J1 (ES Cell)
Model Source: 11875047; Jackson Laboratories (Cat# 005680)

M_TSC1_14_CKO_HT

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Tsc1 conditional-ready floxed mice were crossed to pv-cre mice. in the conditional-ready mice, a floxed neo-tk cassette was inserted into the intron preceding exon 17 and a third loxp site was introduced downstream of exon 18 by homologous recombination. to confirm the time course and specificity of cre expression in pv-cre mice were crossed with rce^gfp reporter mice. (pv-cre; tsc1flox/+ mice)
Allele Type: Conditional knockout
Strain of Origin: 129S4/SvJae
Genetic Background: Not reoprted
ES Cell Line: NA
Mutant ES Cell Line: J1 (ES Cell)
Model Source: 11875047; Jackson Laboratories (Cat# 005680)

M_TSC1_15_CKO_HM

Model Type: Genetic LOF
Model Genotype: Homozygous
Mutation: Tsc1 conditional-ready floxed mice were crossed to nkx2.1-cre mice. in the conditional-ready mice, a floxed neo-tk cassette was inserted into the intron preceding exon 17 and a third loxp site was introduced downstream of exon 18 by homologous recombination. to confirm the time course and specificity of cre expression in nkx2.1-cre mice were crossed with rce^gfp reporter mice. (nkx2.1-cre; tsc1flox/flox mice). nkx2.1 is a transcription factor expressed at e10.5 by gabaergic cell precursors in the medial ganglionic eminence (mge), which gives rise to cortical pv- and somatostatin-expressing (sst) gabaergic cells.
Allele Type: Conditional knockout
Strain of Origin: 129S4/SvJae
Genetic Background: Not reoprted
ES Cell Line: NA
Mutant ES Cell Line: J1 (ES Cell)
Model Source: 11875047; Jackson Laboratories (Cat# 005680)

M_TSC1_16_CKO_HT

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Tsc1 conditional-ready floxed mice were crossed to nkx2.1-cre mice. in the conditional-ready mice, a floxed neo-tk cassette was inserted into the intron preceding exon 17 and a third loxp site was introduced downstream of exon 18 by homologous recombination. to confirm the time course and specificity of cre expression in pv-cre mice were crossed with rce^gfp reporter mice. (nkx2.1-cre; tsc1flox/+ mice). nkx2.1 is a transcription factor expressed at e10.5 by gabaergic cell precursors in the medial ganglionic eminence (mge), which gives rise to cortical pv- and somatostatin-expressing (sst) gabaergic cells.
Allele Type: Conditional knockout
Strain of Origin: 129S4/SvJae
Genetic Background: Not reoprted
ES Cell Line: NA
Mutant ES Cell Line: J1 (ES Cell)
Model Source: 11875047; Jackson Laboratories (Cat# 005680)

M_TSC1_1_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Brain development1
Abnormal
Description: Mildly retarded brain development assessed by neuroepithelial cell proliferation and organziation with a visible developmental delay
Exp Paradigm: Immunohistochemical analysis
 Immunohistochemistry
 E9-12.5
Developmental trajectory1
Abnormal
Description: Delayed development; pale skin; increased edema with pericardial effusion; hypoplastic liver with abnormal growth of abdominal organs
Exp Paradigm: General observation; histological analysis- histology
 Histology
 E9-12.5
Cardiovascular development and function1
Abnormal
Description: Increased heart size with abnormal location
Exp Paradigm: General observations
 General observations
 E9-12.5
Mortality/lethality1
Increased
Description: Increased embryonic lethality
Exp Paradigm: General observations
 General observations
 < e13.5
Developmental trajectory1
Abnormal
Description: Delayed development; pale skin; increased edema with pericardial effusion; hypoplastic liver with abnormal growth of abdominal organs
Exp Paradigm: General observation; histological analysis-general observations
 General observations
 E9-12.5
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_TSC1_2_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Developmental trajectory1
Abnormal
Description: Increased size and presence of lesions consisting of vascular channels of highly variable size which consisted of cuboidal-columnar endothelial cells and smooth muscle cells
Exp Paradigm: Histological analysis
 Histology
 Unreported
Developmental trajectory1
Abnormal
Description: Abnormal development of multiple bilateral renal cystadenomas with progression to renal cell carcinoma
Exp Paradigm: Histological analysis
 Histology
 15-18 months
Mortality/lethality1
Increased
Description: Increased rate of lethality
Exp Paradigm: General observation of female mice-survival analysis: female mice
 Survival analysis
 15-18 months
Mortality/lethality1
Increased
Description: Increased rate of lethality
Exp Paradigm: General observation of female mice- histology: liver
 Histology
 15-18 months
Mortality/lethality1
 No change
 Survival analysis
 15-18 months
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_TSC1_3_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Brain morphology1
Abnormal
Description: Abnormal morphology demonstrated by increased astrocyte number in neocortex and hippocampus
Exp Paradigm: Histological analysis of neocortex and hippocampus
 Histology
 Unreported
Size/growth1
Decreased
Description: Decreased weight gain
Exp Paradigm: General observations
 General observations
 Unreported
Mortality/lethality1
Increased
Description: Increased lethality related to acute seizures/status epilepticus or malnutrition/dehydration
Exp Paradigm: General observations
 General observations
 7-10 weeks
Seizures1
 No change
 Electroencephalogram (eeg)
 3 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Sensory, Social behavior

M_TSC1_4_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Neuronal size1
Increased
Description: Increased area of gabaergic neurons and increased cell size in cerebral cortex and hippocampus
Exp Paradigm: Cell counting and size analyses of coronal brain sections
 Cell size measurement
 P20-p23
Neuronal number: inhibitory neurons1
Decreased
Description: Decreased number of gaba-positive neurons within rostral and parietal regions of neocortex and dentate gyrus of hippocampus
Exp Paradigm: Cell counting and size analyses of coronal brain sections
 Cell counting
 P20-p23
Brain cytoarchitecture1
Abnormal
Description: Abnormal cytoarchitecture indicated by large p86 positive cells in isolation or cluters within neocortical layer i
Exp Paradigm: Cell counting and size analyses of coronal brain sections
 Histology
 P20-p23
Seizures1
Increased
Description: Increased latency to clonic-forebrain seizures with continued flurothyl expsoure
Exp Paradigm: Synchronized video-electroencephalography (eeg) monitoring after treatment with flurothyl, a volatile chemoconvulsant
 Electroencephalogram (eeg)
 P18-p185
Seizures1
Decreased
Description: Decreased latency to onset of seizure induction with flurothyl
Exp Paradigm: Synchronized video-electroencephalography (eeg) monitoring after treatment with flurothyl, a volatile chemoconvulsant
 Electroencephalogram (eeg)
 P18-p185
Size/growth1
Decreased
Description: Decreased size
Exp Paradigm: General observations
 General observations
 P2
Mortality/lethality1
Increased
Description: Increased lethality
Exp Paradigm: General observations
 General observations
 4 weeks
General characteristics1
 No change
 General observations
 Unreported
Brain size1
 No change
 Immunohistochemistry
 P20-p27
Seizures1
 No change
 Electroencephalogram (eeg)
 P18-p185
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Sensory, Social behavior

M_TSC1_5_CKO_HM_PURKINJEN

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Motor learning3
Decreased
Description: Mutant mice with tsc1 deleted in purkinje cells show decrease in latency to fall from the rotarod compared with controls.
Exp Paradigm: NA
 Accelerating rotarod test
 10-11, 15-17 weeks
General locomotor activity: ambulatory activity3
Decreased
Description: Mutant mice with tsc1 deleted in purkinje cells show decrease in distance travelled on the open field compared with controls.
Exp Paradigm: NA
 Open field test
 12-14 weeks
General locomotor activity: ambulatory activity3
Decreased
Description: Mutant mice with tsc1 deleted in purkinje cells show decrease in distance travelled in the elevated plus maze compared with controls.
Exp Paradigm: NA
 Elevated plus maze test
 12-14 weeks
Neuronal number: purkinje cells3
Decreased
Description: Mutant mice with tsc1 deleted in purkinje cells show decrease in purkinje cell numbers compared with controls.
Exp Paradigm: NA
 Immunohistochemistry
 11 weeks
Neuronal number: purkinje cells1
Decreased
Description: Decreased purkinje cell (pc) numbers in the pc layer
Exp Paradigm: Hematoxylin & eosin staining
 Histology
 2 -4 months
Cerebellar morphology3
Abnormal
Description: Mutant mice with tsc1 deleted in purkinje cells show increase in volumes of crusi, crusii and decrease in volumes of lateral nucleus, medial nucleus, interposed nucleus, anterior lobule, compared with controls.
Exp Paradigm: NA
 Diffusion tensor imaging (dti)
 11 weeks
Neuronal activation3
Decreased
Description: Mutant mice with tsc1 deleted in purkinje cells show decrease in purkinje cell excitability compared with controls.
Exp Paradigm: NA
 Whole-cell voltage clamp
 11 weeks
Action potential property: firing rate3
Decreased
Description: Mutant mice with tsc1 deleted in purkinje cells show decrease in spontaneous firing frequency in purkinje cells compared with controls.
Exp Paradigm: NA
 Whole-cell voltage clamp
 11 weeks
Self grooming: perseveration3
Increased
Description: Mutant mice with tsc1 deleted in purkinje cells spend more time self-grooming compared with controls.
Exp Paradigm: NA
 Water t-maze test
 13-15 weeks
Social memory3
Decreased
Description: Mutant mice with tsc1 deleted in purkinje cells spent less time with a novel animal compared with controls.
Exp Paradigm: NA
 Three-chamber social approach test
 12-14, 15-17 weeks
Social approach3
Decreased
Description: Mutant mice with tsc1 deleted in purkinje cells spent reduced time with the social stimulus compared with controls.
Exp Paradigm: NA
 Three-chamber social approach test
 12-14, 15-17 weeks
Social interaction1
Decreased
Description: Decreased social novelty indicated by no significant preference for novel over familiar animal
Exp Paradigm: Three chambered assay for social interaction with a novel mouse and a familiar mouse
 Three-chamber social approach test
 Unreported
Social interaction1
Decreased
Description: Decreased social interaction demonstrated by no difference in time spent with novel mouse vs. object
Exp Paradigm: Three chambered assay for social interaction with a novel mouse and an object
 Three-chamber social approach test
 Unreported
Social scent marking or recognition3
Decreased
Description: Mutant mice with tsc1 deleted in purkinje cells show decrease in time spent investigating social odorants compared with controls.
Exp Paradigm: NA
 Olfactory discrimination test
 12-14, 15-17 weeks
Social interaction1
Decreased
Description: Decreased male-female social interaction demonstrated by reduction in time spent interaction
Exp Paradigm: Open field male female interaction paradigm
 Reciprocal social interaction test
 Unreported
Ultrasonic vocalization1
Increased
Description: Increased ultrasonic vocalizations
Exp Paradigm: Mother-pup seperation induced vocalizations
 Monitoring ultrasonic vocalizations
 P5-p12
Anxiety3
Increased
Description: Mutant mice with tsc1 deleted in purkinje cells show decrease in time spent in the center of the open field compared with controls.
Exp Paradigm: NA
 Open field test
 12-14 weeks
Eye blink conditioning2
Decreased
Description: L7-tsc1 homozygous mice do not learn the conditioned response at all in the eye blink conditioning
Exp Paradigm: Males only
 Eyeblink conditioning
 2-4 months
Cognitive flexibility3
Decreased
Description: Mutant mice with tsc1 deleted in purkinje cells show decrease in ability to locate the platform when it was switched to the opposite quadrant compared with controls.
Exp Paradigm: NA
 Water t-maze test
 13-15 weeks
Protein phosphorylation1
Increased
Description: Increased levels of phosphorylated s6 (ps6) in cerebellar pcs
Exp Paradigm: Phosphorylated s6 levels
 NA
 Unreported
Signaling: mtor pathway3
Increased
Description: Mutant mice with tsc1 deleted in purkinje cells show increase in phosphos6 compared with controls.
Exp Paradigm: NA
 Immunohistochemistry
 11 weeks
Mortality/lethality1
 No change
 General observations
 Unreported
Anxiety3
 No change
 Elevated plus maze test
 12-14 weeks
Spatial learning1
 No change
 Water t-maze test
 Unreported
Spatial working memory3
 No change
 Water t-maze test
 13-15 weeks
General locomotor activity1
 No change
 Three-chamber social approach test
 Unreported
Brain cytoarchitecture1
 No change
 Histology
 Unreported
Brain size3
 No change
 Diffusion tensor imaging (dti)
 11 weeks
Synaptic transmission1
 No change
 Field potential recordings
 Unreported
Olfaction3
 No change
 Olfactory discrimination test
 12-14, 15-17 weeks
Olfaction1
 No change
 Olfactory discrimination test
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Maternal behavior, Molecular profile, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_TSC1_5_CKO_HT_PURKINJEN

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Action potential property: firing rate1
Decreased
Description: Decreased spontaneous spiking rate and ap firing in response to current injection
Exp Paradigm: Extracellular recordings
 Field potential recordings
 Unreported
Self grooming: perseveration1
Increased
Description: Increased self grooming rates
Exp Paradigm: Repetitive grooming task
 Grooming behavior assessments
 Unreported
Self grooming: perseveration3
Increased
Description: Het mice with tsc1 deleted in purkinje cells spend more time self-grooming compared with controls.
Exp Paradigm: NA
 Water t-maze test
 13-15 weeks
Social memory3
Decreased
Description: Het mice with tsc1 deleted in purkinje cells spent less time with a novel animal compared with controls.
Exp Paradigm: NA
 Three-chamber social approach test
 12-14 weeks
Social interaction1
Decreased
Description: Decreased social interaction demonstrated by no difference in time spent with novel mouse vs. object
Exp Paradigm: Three chambered assay for social interaction with a novel mouse and an object
 Three-chamber social approach test
 Unreported
Social approach3
Decreased
Description: Het mice with tsc1 deleted in purkinje cells spent reduced time with the social stimulus compared with controls.
Exp Paradigm: NA
 Three-chamber social approach test
 12-14 weeks
Social scent marking or recognition3
Decreased
Description: Het mice with tsc1 deleted in purkinje cells show decrease in time spent investigating social odorants compared with controls.
Exp Paradigm: NA
 Olfactory discrimination test
 15-17 weeks
Ultrasonic vocalization1
Increased
Description: Increased ultrasonic vocalizations
Exp Paradigm: Mother-pup seperation induced vocalizations
 Monitoring ultrasonic vocalizations
 P5-p12
Anxiety3
Increased
Description: Het mice with tsc1 deleted in purkinje cells show decrease in time spent in the center of the open field compared with controls.
Exp Paradigm: NA
 Open field test
 12-14 weeks
Eye blink conditioning2
Decreased
Description: L7-tsc1 hets have significantly reduced learning of the cr in eyeblink conditioning accompanied by a significantly reduced response amplitude. the latter represents the neural representation of the learned response of eye blinking.
Exp Paradigm: Males only
 Eyeblink conditioning
 2-4 months
Cognitive flexibility3
Decreased
Description: Het mice with tsc1 deleted in purkinje cells show decrease in ability to locate the platform when it was switched to the opposite quadrant compared with controls.
Exp Paradigm: NA
 Water t-maze test
 13-15 weeks
Protein phosphorylation1
Increased
Description: Increased levels of phosphorylated s6 (ps6) in cerebellar pcs
Exp Paradigm: Phosphorylated s6 levels
 NA
 Unreported
Signaling: mtor pathway3
Increased
Description: Het mice with tsc1 deleted in purkinje cells show increase in phosphos6 compared with controls.
Exp Paradigm: NA
 Immunohistochemistry
 11 weeks
Mortality/lethality1
 No change
 General observations
 Unreported
Anxiety3
 No change
 Elevated plus maze test
 12-14 weeks
Eye blink conditioning: extinction and reactivation2
 No change
 Eyeblink conditioning
 2-4 months
Spatial learning2
 No change
 Water y-maze test
 2-4 months
Spatial learning1
 No change
 Water t-maze test
 Unreported
Spatial working memory3
 No change
 Water t-maze test
 13-15 weeks
Gait2
 No change
 Running stride analysis
 2-4 months
General locomotor activity1
 No change
 Three-chamber social approach test
 Unreported
General locomotor activity1
 No change
 Open field test
 Unreported
General locomotor activity: ambulatory activity3
 No change
 Elevated plus maze test
 12-14 weeks
General locomotor activity: ambulatory activity3
 No change
 Open field test
 12-14 weeks
Motor learning3
 No change
 Accelerating rotarod test
 10-11 weeks
Cerebellar morphology: granule cell layer thickness2
 No change
 Histology
 2-4 months
Cerebellar morphology: molecular layer thickness2
 No change
 Histology
 2-4 months
Dendritic architecture: dendritic tree complexity2
 No change
 Sholl analysis
 2-4 months
Dendritic architecture: spine density2
 No change
 Sholl analysis
 2-4 months
Neuronal number: purkinje cells3
 No change
 Immunohistochemistry
 11 weeks
Neuronal number: purkinje cells1
 No change
 Histology
 Unreported
Olfaction3
 No change
 Olfactory discrimination test
 12-14 weeks
Olfaction1
 No change
 Olfactory discrimination test
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Maternal behavior, Molecular profile, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_TSC1_12_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Ataxia1
Increased
Description: Increased ataxia indicated by marked changes in the gait parameters
Exp Paradigm: Stride length/width analysis
 Footprint analysis
 Unreported
Motor coordination and balance1
Decreased
Description: Decreased motor learning
Exp Paradigm: Accelerating rotarod test
 Accelerating rotarod test
 Unreported
Neuronal number: purkinje cells1
Increased
Description: Increased purkinje cell soma area
Exp Paradigm: NA
 NA
 Unreported
Dendritic architecture: spine density1
Increased
Description: Increased spine density on pc dendrites
Exp Paradigm: NA
 NA
 Unreported
Action potential property: firing rate1
Decreased
Description: Decreased spontaneous spiking rate and ap firing in response to current injection
Exp Paradigm: Extracellular recordings
 Field potential recordings
 Unreported
Oxidative stress in neurons1
Increased
Description: Increased neuronal stress indicated by elevated levels of er (grp78) and oxidative (ho1) stress in pcs
Exp Paradigm: Immunohistochemical analysis with antibodies for grp78 and ho1
 Immunohistochemistry
 Unreported
Allogrooming: perseveration1
Increased
Description: Increased
Exp Paradigm: Grooming behavior assessments
 Grooming behavior assessments
 Unreported
Social scent marking or recognition1
Decreased
Description: Decreased investigation of social odors
Exp Paradigm: NA
 NA
 Unreported
Size/growth1
Decreased
Description: Decreased body weight
Exp Paradigm: General observations
 General observations
 P7
Mortality/lethality1
Increased
Description: Increased lethality
Exp Paradigm: General observations
 General observations
 P19
Cognitive flexibility1
Decreased
Description: Decreased cognitive flexibility demonstrated by impaired learning of new platform location
Exp Paradigm: Reversal learning paradigm using a water t-maze test
 Water t-maze test
 Unreported
Marker expression1
Increased
Description: Increased apoptosis demonstrated by apoptosis markers in pc
Exp Paradigm: Apoptosis markers
 Tunel assay
 7-8 weeks
Size/growth1
 No change
 General observations
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Maternal behavior, Physiological parameters, Seizure, Sensory

M_TSC1_12_CKO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Neuronal number: purkinje cells1
Increased
Description: Increased purkinje cell soma area
Exp Paradigm: NA
 NA
 Unreported
Dendritic architecture: spine density1
Increased
Description: Increased spine density on pc dendrites
Exp Paradigm: NA
 NA
 Unreported
Oxidative stress in neurons1
Increased
Description: Increased neuronal stress indicated by elevated levels of er (grp78) and oxidative (ho1) stress in pcs
Exp Paradigm: Immunohistochemical analysis with antibodies for grp78 and ho1
 Immunohistochemistry
 Unreported
Social interaction1
Decreased
Description: Decreased social novelty indicated by no significant preference for novel over familiar animal
Exp Paradigm: Three chambered assay for social interaction with a novel mouse and a familiar mouse
 Three-chamber social approach test
 Unreported
Size/growth1
Decreased
Description: Decreased body weight
Exp Paradigm: General observations
 General observations
 P7, 5.7 weeks
Depression1
Increased
Description: Increased depression as measured by immobility time
Exp Paradigm: Forced swim test
 Forced swim test
 5.7 weeks
Cognitive flexibility1
Decreased
Description: Decreased cognitive flexibility demonstrated by impaired learning of new platform location
Exp Paradigm: Reversal learning paradigm using a water t-maze test
 Water t-maze test
 Unreported
Size/growth1
 No change
 General observations
 Unreported
Anxiety1
 No change
 Open field test
 5.7 weeks
Anxiety1
 No change
 Elevated plus maze test
 5.7 weeks
Depression1
 No change
 Tail suspension test
 5.7 weeks
Ataxia1
 No change
 Footprint analysis
 Unreported
General locomotor activity1
 No change
 Open field test
 5.7 weeks
Seizures1
 No change
 Electroencephalogram (eeg)
 5.7 weeks
Seizures1
 No change
 Electroencephalogram (eeg)
 5.7 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Immune response, Maternal behavior, Molecular profile, Physiological parameters, Repetitive behavior, Sensory

M_TSC1_7_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Self grooming2
Increased
Description: Tsc1 mutant mice exhibited more frequent self-grooming behavior compared to wildtype controls.
 Grooming behavior assessments
 10 months
Pain or nociception1
Decreased
Description: Decreased pain sensitivity indicated by longer latency
Exp Paradigm: Male mice: tail flick test
 Tail flick test
 3-7 months
Social interaction2
Decreased
Description: Tsc1 mutant mice exhibited a decrease in the amount of time spent interacting with a wildtype mate of the same sex compared to wildtype controls.
 Reciprocal social interaction test
 4-10 months
Rearing behavior1
Increased
Description: Increased rearing behavior
Exp Paradigm: Social interaction test
 Reciprocal social interaction test
 3-7 months
Social interaction1
Decreased
Description: Decreased social interaction demonstrated by shorter time engaged in active exploration i.e. exploring a novel mouse
Exp Paradigm: Social interaction test with novel mouse scored for sniffing, allo-grooming, mounting, and following
 Reciprocal social interaction test
 3-7 months
Social interaction1
Decreased
Description: Decreased active interaction
Exp Paradigm: Social interaction test
 Reciprocal social interaction test
 3-7 months
Social memory2
Decreased
Description: Tsc1 mutant mice exhibited impaired social memory compared to control mice, spending comparable amounts of time exploring the novel versus familiar (non-cagemate) mouse, whereas wildtype mice spent significantly more time exploring the novel mouse.
Exp Paradigm: Novel mouse: stranger (S2); Familiar mouse: non-cagemate previously introduced for 10 mins (S1).
 Three-chamber social approach test
 3-10 months
Rearing behavior1
Increased
Description: Increased rearing behavior
Exp Paradigm: Social interaction test with novel mouse scored for rearing
 Reciprocal social interaction test
 3-7 months
Anxiety1
Decreased
Description: Decreased anxiety levels indicated by less time spent in dark chamber
Exp Paradigm: Male mice: light-dark exploration test
 Light-dark exploration test
 3-7 months
Differential gene expression2
Abnormal
Description: Tsc1 mutant mice exhibited 1523 differentially expressed transcripts compared to wildtype controls.
 RNA sequencing
 3 months
General characteristics1
 No change
 General observations
 3-7 months
Size/growth1
 No change
 General observations
 3-7 months
Anxiety1
 No change
 Light-dark exploration test
 3-7 months
Anxiety2
 No change
 Elevated plus maze test
 3-6 months
Depression1
 No change
 Tail suspension test
 3-7 months
Exploratory activity1
 No change
 Home cage behavior
 3-7 months
General locomotor activity1
 No change
 Open field test
 8-10 weeks
General locomotor activity: ambulatory activity2
 No change
 Elevated plus maze test
 3-6 months
Grip strength1
 No change
 Vertical pole test
 8-10 weeks
Motor coordination and balance1
 No change
 Accelerating rotarod test
 8-10 weeks
Rearing behavior2
 No change
 Grooming behavior assessments
 10 months
Repetitive nose pokes2
 No change
 Hole-board test
 3-5 months
Olfaction1
 No change
 Buried food test
 3-7 months
Pain or nociception1
 No change
 Tail flick test
 3-7 months
Social approach2
 No change
 Three-chamber social approach test
 3-10 months
Social dominance1
 No change
 Tube test of social dominance
 3-7 months
Social memory2
 No change
 Three-chamber social approach test
 3-10 months
Social transmission of food preference2
 No change
 Social transmission of food preference
 4-5 months
 Not Reported: Circadian sleep/wake cycle, Communications, Immune response, Learning & memory, Maternal behavior, Molecular profile, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure

M_TSC1_8_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Anatomical projections and connectivity1
Abnormal
Description: Abnormal tca indicated by not localized to barrel hollows; improperly patterned cortical barrels; larger average barrel size
Exp Paradigm: Cytochrome oxidase (co) staining of thalamocortical circuits
 Immunohistochemistry
 Unreported
Neuronal size: active neurons1
Increased
Description: Increased geometric mean soma rea of ps6+ neurons
Exp Paradigm: Immunohistochemical analysis using somatodendritic marker microtubule-associated protein 2 (map2)
 Immunohistochemistry
 Unreported
Neuronal number: purkinje cells1
Decreased
Description: Decreased neuron density in barrel wall region in cortex
Exp Paradigm: Neun antibody labeling with co staining in barrel hollows
 Immunohistochemistry
 Unreported
Anatomical projections and connectivity1
Abnormal
Description: Abnormal thalamocortical circuit development indicated by diffuse pattern of cortical innervation: individual barrels were indistinguishable in layer iv and overabundant projections in deep layers of thalamic ventrobasal nuclear complex to vibrissa barrels in layer iv of primary somatosensory cortex
Exp Paradigm: Immunohistochemical analysis using r26tdtomato to label thalamic projections
 Immunohistochemistry
 Unreported
Action potential property: rate of depolarization1
Increased
Description: Faster rates of depolarization
Exp Paradigm: Whole-cell patch clamp recordings on thalamic vb neurons in mature thalamocortical slices
 Whole-cell patch clamp
 Unreported
Synaptic transmission1
Abnormal
Description: Abnormal neural activity indicated by higher power across multiple frequencies, especially 3 hz range
Exp Paradigm: Local field potentials in vibrissal representation of primary si
 In vivo local field potential (lfp) recordings
 Unreported
Action potential property: firing pattern1
Abnormal
Description: Abnormal firing properties demonstrated by constant amplitude of action potential during tonic firing and mean spiking frequency during burst firing
Exp Paradigm: NA
 Whole-cell patch clamp
 Unreported
Intrinsic membrane properties1
Abnormal
Description: Abnormal intrinsic membrane properties indicated by lower input resistance and higher capacitance
Exp Paradigm: Whole-cell patch clamp recordings on thalamic vb neurons in mature thalamocortical slices
 Whole-cell patch clamp
 Unreported
Action potential property: amplitude1
Increased
Description: Larger spike amplitude
Exp Paradigm: Whole-cell patch clamp recordings on thalamic vb neurons in mature thalamocortical slices
 Whole-cell patch clamp
 Unreported
Action potential property: rate of repolarization1
Increased
Description: Faster rates of repolarization
Exp Paradigm: Whole-cell patch clamp recordings on thalamic vb neurons in mature thalamocortical slices
 Whole-cell patch clamp
 Unreported
Action potential property: after hyperpolarization1
Increased
Description: More negative afterpotentials
Exp Paradigm: Whole-cell patch clamp recordings on thalamic vb neurons in mature thalamocortical slices
 Whole-cell patch clamp
 Unreported
Self grooming: perseveration1
Increased
Description: Increased self grooming rates resulting in severe skin lesions
Exp Paradigm: Homecage behavior observations
 Grooming behavior assessments
 2 months
Seizures1
Increased
Description: Increased spontaneous seizures with highly stereotyped behavior, followed by loss of upright posture, then a tonic-clonic state with convulsive, twisted posture
Exp Paradigm: General observations
 General observations
 2 months
Enzyme activity1
Increased
Description: Increased mtor activity in thalamus
Exp Paradigm: Mtor activity
 Immunohistochemistry
 E14.5, e17.5
Grip strength1
 No change
 Wire hang test
 Unreported
Myelination1
 No change
 Immunohistochemistry
 Unreported
Pain or nociception1
 No change
 Hot plate test
 Unreported
Touch1
 No change
 Von frey filament test
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Physiological parameters, Social behavior

M_TSC1_9_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Synaptic transmission1
Abnormal
Description: Abnormal neural activity indicated by higher power across multiple frequencies, especially 3 hz range
Exp Paradigm: Local field potentials in vibrissal representation of primary si
 In vivo local field potential (lfp) recordings
 Unreported
Seizures1
Increased
Description: Increased incidence of rare seizures
Exp Paradigm: General observations
 General observations
 8 months
Enzyme activity1
Increased
Description: Increased mtor activity in thalamus
Exp Paradigm: Mtor activity
 Immunohistochemistry
 Unreported
Protein expression level evidence1
 No change
 Immunohistochemistry
 Unreported
Neuronal size: active neurons1
 No change
 Immunohistochemistry
 Unreported
Somatosensory cortical map architecture1
 No change
 NA
 Unreported
Action potential property: amplitude1
 No change
 Whole-cell patch clamp
 Unreported
Action potential property: firing pattern1
 No change
 Whole-cell patch clamp
 Unreported
Action potential property: rate of depolarization1
 No change
 Whole-cell patch clamp
 Unreported
Action potential property: rate of repolarization1
 No change
 Whole-cell patch clamp
 Unreported
Intrinsic membrane properties1
 No change
 Whole-cell patch clamp
 Unreported
Self grooming: perseveration1
 No change
 Grooming behavior assessments
 3 months
Seizures1
 No change
 General observations
 2 months
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Motor phenotype, Physiological parameters, Sensory, Social behavior

M_TSC1_10_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine density1
Increased
Description: At p29-30, after the spinal pruning stage and when most deep cortical neurons lack tsc1 in the tsc1 cn ko mice, the density of spine is increased in the pyramidal neurons of layer v auditory and secondary somatosensory cortices
Exp Paradigm: NA
 Histology
 4 weeks
Dendritic architecture: dendritic tree complexity1
 No change
 Histology
 4 weeks
Dendritic architecture: spine density1
 No change
 Histology
 P19-20
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_TSC1_11_CKO_HM_PURKINJEN

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Action potential property: firing rate1
Decreased
Description: Tsc1 mutant mice show decreased purkinje neuron firing compared to controls.
Exp Paradigm: NA
 Field potential recordings
 Unreported
Functional magnetic resonance imaging: connectivity1
Abnormal
Description: Tsc1 mutant mice showed significant changes in structural connectivity between bilateral crusi and multiple contralateral cortical areas compared to controls. tsc1 mutant mice showed significant increase in structural connectivity between rcrusi white matter and parietal association areas compared to controls. tsc1 mutant mice show abnormal asymmetric structural connectivity between the right and left crusi and contralateral cerebral cortices, compared to controls.
Exp Paradigm: NA
 Magnetic resonance imaging (mri)
 Unreported
Self grooming: perseveration1
Increased
Description: Tsc1 mutant mice showed increased grooming compared to controls.
Exp Paradigm: NA
 Grooming behavior assessments
 Unreported
Social approach1
Decreased
Description: Tsc1 mutant mice showed impaired social approach compared to controls.
Exp Paradigm: NA
 Three-chamber social approach test
 Unreported
Social memory1
Decreased
Description: Tsc1 mutant mice showed impaired social novelty compared to controls.
Exp Paradigm: NA
 Three-chamber social approach test
 Unreported
Cognitive flexibility1
Decreased
Description: Tsc1 mutant mice showed increased behavioral inflexibility compared to controls, measured by reduced performance in the reversal learning task.
Exp Paradigm: NA
 Y-maze test
 Unreported
Anxiety1
 No change
 Elevated plus maze test
 Unreported
Anxiety1
 No change
 Open field test
 Unreported
General locomotor activity: ambulatory activity1
 No change
 Elevated plus maze test
 Unreported
Motor coordination and balance1
 No change
 Accelerating rotarod test
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Immune response, Maternal behavior, Molecular profile, Neuroanatomy / ultrastructure / cytoarchitecture, Physiological parameters, Seizure, Sensory

M_TSC1_12_KD

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: ambulatory activity1
Increased
Description: Tsc1-sirna injected mice show increase in distance travelled on the open field compared with controls.
Exp Paradigm: NA
 Open field test
 Adult
Self grooming: perseveration1
Increased
Description: Tsc1-sirna injected mice show increase in repetitive self-grooming compared with controls.
Exp Paradigm: NA
 Grooming behavior assessments
 Adult
Repetitive digging1
Decreased
Description: Tsc1-sirna injected mice show decrease in the number of marbles buried in the home cage compared with controls.
Exp Paradigm: NA
 Marble-burying test
 Adult
Social memory1
Decreased
Description: Tsc1-sirna injected mice show decrease in preference for an unfamiliar over a familiar mouse compared with controls.
Exp Paradigm: NA
 U-field assay
 Adult
Social approach1
Decreased
Description: Tsc1-sirna injected mice show no preference for a social stimulus over an empty cage compared with controls and spend less time interacting with the social target compared with controls.
Exp Paradigm: NA
 Three-chamber social approach test
 Adult
Object recognition memory1
Decreased
Description: Tsc1-sirna injected mice show decrease in time spent with an unfamiliar object over a familiar object compared with controls.
Exp Paradigm: NA
 Object preference test
 Adult
Targeted expression1
Decreased
Description: Tsc1-sirna injected mice show decrease in tsc1 transcript in the dorsal striatum, 2 days after injection.
Exp Paradigm: Striatal tissue was used for qrt pcr.
 Quantitative pcr (qrt-pcr)
 Adult
Repetitive digging1
 No change
 Home cage behavior
 Adult
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Maternal behavior, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Seizure, Sensory

M_TSC1_13_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Neuronal morphology1
Abnormal
Description: Increased soma size
 Electron microscopy
 Adult
Synaptic morphology1
Decreased
Description: Length of pv+ synapses were significantly reduced
 Electron microscopy
 Adult
Dendritic architecture: dendritic tree complexity1
Abnormal
Description: Purkinje cell dendritic arbors were severely abnormal
 Immunohistochemistry
 Adult
Synapse density: Inhibitory1
Decreased
Description: Decreased perisomatic parvalbumin and gephrin synapse density; decreased density of pv+ terminals
 Immunohistochemistry
 Adult
Cerebellar morphology1
Abnormal
Description: Abnormal morphology and cytoarchitecture of the cerebellum
 Immunohistochemistry
 Adult
Neuronal number: Purkinje cells1
Decreased
Description: Purkinje cell numbers were greatly reduced
 Immunohistochemistry
 Adult
Social approach1
Decreased
Description: Decrease in time spent exploring a mouse over an object
 Three-chamber social approach test
 Adult
Social memory1
Decreased
Description: No preference for novel mouse over familiar mouse
 Three-chamber social approach test
 Adult
Anxiety1
Decreased
Description: Increase in time spent in open arms
 Elevated plus maze test
 Adult
Signaling: mTOR pathway1
Increased
Description: At p45 a higher proportion of pv cells co-localized with ps6 and showed a 2.5-fold increase in ps6 intensity in pv cell somata indicating cortical pv cells show increased mtor activity
 Western blot
 P45
General locomotor activity: Ambulatory activity1
 No change
 Open field test
 Adult
Neuronal number: Interneurons1
 No change
 Three-chamber social approach test
 Adult
 Not Reported:

M_TSC1_14_CKO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Anatomical projections and connectivity1
Abnormal
Description: Postnatal onset of tsc1 haploinsufficiency in pv cells induces premature putative synapse formation
 Immunohistochemistry
 P22
Synaptic morphology1
Decreased
Description: Length of pv+ synapses were significantly reduced
 Electron microscopy
 Adult
Synapse density: Inhibitory1
Decreased
Description: Decreased perisomatic parvalbumin and gephrin synapse density; decreased density of pv+ terminals
 Immunohistochemistry
 Adult
Neuronal morphology1
Increased
Description: Increased soma size
 Electron microscopy
 Adult
Social memory1
Decreased
Description: No preference for novel mouse over familiar mouse
 Three-chamber social approach test
 Adult
Social approach1
Decreased
Description: Decrease in time spent exploring a mouse over an object
 Three-chamber social approach test
 Adult
Signaling: mTOR pathway1
Increased
Description: At p45 a higher proportion of pv cells co-localized with ps6 and showed a 2.5-fold increase in ps6 intensity in pv cell somata indicating cortical pv cells show increased mtor activity
 Western blot
 P45
Anxiety1
 No change
 Elevated plus maze test
 Adult
General locomotor activity: Ambulatory activity1
 No change
 Open field test
 Adult
Cerebellar morphology1
 No change
 Immunohistochemistry
 Adult
Neuronal number: Interneurons1
 No change
 Three-chamber social approach test
 Adult
 Not Reported:

M_TSC1_15_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: Ambulatory activity1
Increased
Description: Increase in total distance travelled
 Open field test
 Adult
Anatomical projections and connectivity1
Abnormal
Description: Loss of innervation in mutant pv cells; premature increase of pv cell perisomatic innervation
 Immunohistochemistry
 Adult
Synapse density: Inhibitory1
Decreased
Description: Reduction in the density of vgat+, gephyrin+ puncta in the external plexiform layer of the adult mice olfactory bulb
 Immunohistochemistry
 Adult
Neuronal morphology1
Increased
Description: Increased soma size
 Electron microscopy
 P16
Axonal architecture: axonal branch number1
Decreased
Description: Decrease in axonal branching
 Immunohistochemistry
 Adult
Macroautophagy: neuronal1
Increased
Description: Increased levels of lc3-ii, but not of p62 at p14 but not adult mice
 Western blot
 P14
Social memory1
Decreased
Description: No preference for novel mouse over familiar mouse
 Three-chamber social approach test
 Adult
Social approach1
Decreased
Description: Decrease in time spent exploring a mouse over an object
 Three-chamber social approach test
 Adult
Anxiety1
Increased
Description: Decrease in time spent in open arms
 Elevated plus maze test
 Adult
Signaling: MAPK pathway1
Increased
Description: Increased activation of ampk, as indicated by the expression levels of phospho-ampk (at t172) and a trend towards increased levels of pulk1
 Western blot
 P14
Signaling: mTOR pathway1
Increased
Description: Increase in ps6 levels
 Western blot
 P16, P45
Neuronal number: Interneurons1
 No change
 Immunohistochemistry
 P18
 Not Reported:

M_TSC1_16_CKO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Anatomical projections and connectivity1
Decreased
Description: Loss of innervation in mutant pv cells
 Immunohistochemistry
 Adult
Synapse density: Inhibitory1
Decreased
Description: Decrease in perisomatic bouton density
 Immunohistochemistry
 Adult
Neuronal morphology1
Increased
Description: Increased soma size
 Electron microscopy
 P16
Axonal architecture: axonal branch number1
Decreased
Description: Decreased axonal branching
 Immunohistochemistry
 Adult
Social memory1
Decreased
Description: No preference for novel mouse over familiar mouse
 Three-chamber social approach test
 Adult
Social approach1
Decreased
Description: Decrease in time spent exploring a mouse over an object
 Three-chamber social approach test
 Adult
Signaling: mTOR pathway1
Increased
Description: Increase in ps6 levels
 Western blot
 P16, P45
Anxiety1
 No change
 Elevated plus maze test
 Adult
General locomotor activity: Ambulatory activity1
 No change
 Open field test
 Adult
Neuronal number: Interneurons1
 No change
 Immunohistochemistry
 P18
 Not Reported:


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
ABI1 abl-interactor 1 10006 Q8IZP0 Y2H
Sakai Y , et al. 2011
ACTN1 actinin, alpha 1 87 P12814 Y2H; IP/WB
Sakai Y , et al. 2011
ACTN2 actinin, alpha 2 88 P35609 Y2H
Sakai Y , et al. 2011
AKT1 v-akt murine thymoma viral oncogene homolog 1 207 P31749 IP/WB
Dan HC , et al. 2002
AKTIP AKT-interacting protein 64400 Q9H8T0-2 IP; LC-MS/MS
Huttlin EL , et al. 2015
ANKIB1 ankyrin repeat and IBR domain containing 1 54467 Q9P2G1 Y2H
Sakai Y , et al. 2011
ANKRD24 ankyrin repeat domain 24 170961 Q8TF21 Y2H
Sakai Y , et al. 2011
ANKRD35 ankyrin repeat domain 35 148741 Q8N283 Y2H
Sakai Y , et al. 2011
ATN1 atrophin 1 1822 P54259 Y2H
Sakai Y , et al. 2011
axin1 axin 1 734298 Q9YGY0 IP/WB
Mak BC , et al. 2003
BCL11A B-cell CLL/lymphoma 11A (zinc finger protein) 53335 Q9H165 Y2H
Sakai Y , et al. 2011
BECN1 beclin 1, autophagy related 8678 Q14457 IP; MS; COMPASS
Behrends C , et al. 2010
BEND5 BEN domain containing 5 79656 Q7L4P6 Y2H
Sakai Y , et al. 2011
C12orf41 chromosome 12 open reading frame 41 54934 Q9H9L4 Y2H
Sakai Y , et al. 2011
C9orf30 chromosome 9 open reading frame 30 91283 Q96H12 Y2H
Sakai Y , et al. 2011
CALCOCO2 calcium binding and coiled-coil domain 2 10241 Q13137 Y2H
Sakai Y , et al. 2011
CASC3 cancer susceptibility candidate 3 22794 O15234 Y2H
Sakai Y , et al. 2011
CCDC88B coiled-coil domain containing 88B 283234 A6NC98 Y2H
Sakai Y , et al. 2011
CCNB1 cyclin B1 891 P14635 IP/WB
Catania MG , et al. 2001
CDK1 cyclin-dependent kinase 1 983 P06493 IP/WB
Catania MG , et al. 2001
CDKN1B cyclin-dependent kinase inhibitor 1B (p27, Kip1) 1027 P46527 IP/WB
Rosner M and Hengstschlger M 2004
CDR2 cerebellar degeneration-related protein 2, 62kDa 1039 Q01850 Y2H
Sakai Y , et al. 2011
CEP110 Centriolar coiled-coil protein of 110 kDa 9738 O43303 Y2H
Sakai Y , et al. 2011
CHD8 chromodomain helicase DNA binding protein 8 57680 Q9HCK8 ChIP-chip
Subtil-Rodrguez A , et al. 2013
CNIH cornichon homolog (Drosophila) 10175 O95406 Y2H
Sakai Y , et al. 2011
CNTROB centrobin, centrosomal BRCA2 interacting protein 116840 Q8N137 Y2H
Sakai Y , et al. 2011
COG6 component of oligomeric golgi complex 6 57511 Q9Y2V7 Y2H
Sakai Y , et al. 2011
CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa 1499 Q9WU82 Y2H
Sakai Y , et al. 2011
CUL4A cullin 4A 8451 Q13619 IP/WB
Hu J , et al. 2008
DACH2 dachshund homolog 2 (Drosophila) 117154 Q96NX9 Y2H
Sakai Y , et al. 2011
DCTN2 dynactin 2 (p50) 10540 Q13561 Y2H
Sakai Y , et al. 2011
DDB1 damage-specific DNA binding protein 1, 127kDa 1642 Q16531 IP/WB
Hu J , et al. 2008
DDIT4 DNA-damage-inducible transcript 4 54541 Q9NX09 IP/WB
Vega-Rubin-de-Celis S , et al. 2010
DOCK7 dedicator of cytokinesis 7 85440 Q96N67 IP; MS; IP/WB
Nellist M , et al. 2005
EIF3A eukaryotic translation initiation factor 3, subunit A 8661 Q14152 Y2H
Sakai Y , et al. 2011
EZR ezrin 7430 P15311 Y2H; GST; IP/WB
Lamb RF , et al. 2000
FBF1 Fas (TNFRSF6) binding factor 1 85302 Q8TES7 Y2H
Sakai Y , et al. 2011
FBXW5 F-box and WD repeat domain containing 5 54661 Q969U6 IP/WB
Hu J , et al. 2008
FMR1 fragile X mental retardation 1 2332 G8JLE9 PAR-CLIP
Ascano M Jr , et al. 2012
FTH1 ferritin, heavy polypeptide 1 2495 P02794 Y2H; GST
Sakai Y , et al. 2011
GCC1 GRIP and coiled-coil domain containing 1 79571 Q96CN9 Y2H
Sakai Y , et al. 2011
GEMIN8 gem (nuclear organelle) associated protein 8 54960 Q9NWZ8 Y2H
Sakai Y , et al. 2011
GFAP glial fibrillary acidic protein 2670 P14136 Y2H
Sakai Y , et al. 2011
GOLGA2 golgin A2 2801 Q08379 Y2H
Sakai Y , et al. 2011
GPATCH1 G patch domain containing 1 55094 Q9BRR8 Y2H
Sakai Y , et al. 2011
GSK3B glycogen synthase kinase 3 beta 2932 P49841 IP/WB
Mak BC , et al. 2003
HECW1 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 23072 Q76N89 Y2H
Sakai Y , et al. 2011
HGS hepatocyte growth factor-regulated tyrosine kinase substrate 9146 O14964 Y2H
Sakai Y , et al. 2011
HNRNPM heterogeneous nuclear ribonucleoprotein M 4670 P52272 Y2H
Sakai Y , et al. 2011
HOMER3 homer homolog 3 (Drosophila) 9454 Q9NSC5 Y2H; IP/WB
Sakai Y , et al. 2011
HOOK2 hook homolog 2 (Drosophila) 29911 Q96ED9 Y2H
Sakai Y , et al. 2011
ICA1 islet cell autoantigen 1, 69kDa 3382 Q05084 Y2H
Sakai Y , et al. 2011
IKBKB inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 3551 O14920 IP/WB; in vitro kinase assay
Lee DF , et al. 2007
KIAA1026 KIAA1026 protein B7ZL87 Y2H; GST
Sakai Y , et al. 2011
KIF1C kinesin family member 1C 10749 O43896 Y2H
Sakai Y , et al. 2011
KIF5A kinesin family member 5A 3798 Q12840 Y2H
Sakai Y , et al. 2011
KLC1 kinesin light chain 1 3831 Q07866 Y2H
Sakai Y , et al. 2011
KLC4 kinesin light chain 4 89953 Q9NSK0 Y2H
Sakai Y , et al. 2011
LOC347475 coiled-coil domain containing 160 347475 A6NGH7 Y2H
Sakai Y , et al. 2011
LRSAM1 leucine rich repeat and sterile alpha motif containing 1 90678 Q6UWE0 Y2H
Sakai Y , et al. 2011
LUC7L LUC7-like (S. cerevisiae) 55692 Q9NQ29 Y2H
Sakai Y , et al. 2011
LZTS2 leucine zipper, putative tumor suppressor 2 84445 Q9BRK4 Y2H
Sakai Y , et al. 2011
MAPKAP1 mitogen-activated protein kinase associated protein 1 79109 Q9BPZ7 IP/WB
Huang J , et al. 2009
MBIP MAP3K12 binding inhibitory protein 1 51562 Q9NS73 Y2H
Sakai Y , et al. 2011
MBP myelin basic protein 4155 P02686 Y2H
Sakai Y , et al. 2011
MLST8 MTOR associated protein, LST8 homolog (S. cerevisiae) 64223 Q9BVC4 IP/WB
Huang J , et al. 2009
MT-ND1 mitochondrially encoded NADH dehydrogenase 1 4535 P03886 Y2H
Sakai Y , et al. 2011
MTOR mechanistic target of rapamycin (serine/threonine kinase) 2475 P42345 IP/WB
Maiese K , et al. 2012
NECAB2 N-terminal EF-hand calcium binding protein 2 54550 Q7Z6G3 Y2H
Sakai Y , et al. 2011
NEFL neurofilament, light polypeptide 4747 P07196 Y2H; GST; IP/WB
Haddad LA , et al. 2002
NF2 neurofibromin 2 (merlin) 4771 P35240 GST
Haddad LA , et al. 2002
NGFRAP1 nerve growth factor receptor (TNFRSF16) associated protein 1 27018 Q00994 Y2H; GST; IP/WB
Yasui S , et al. 2007
NINL ninein-like 22981 Q9Y2I6 Y2H
Sakai Y , et al. 2011
NKD2 naked cuticle homolog 2 (Drosophila) 85409 Q969F2 Y2H
Sakai Y , et al. 2011
NRBF2 nuclear receptor binding factor 2 29982 Q96F24 Y2H
Sakai Y , et al. 2011
PHLDB1 pleckstrin homology-like domain, family B, member 1 23187 Q86UU1 Y2H
Sakai Y , et al. 2011
PICK1 protein interacting with PRKCA 1 9463 Q9NRD5 Y2H; GST
Sakai Y , et al. 2011
PLK1 polo-like kinase 1 5347 P53350 IP/WB
Astrinidis A , et al. 2005
PLK2 polo-like kinase 2 10769 Q9NYY3 IP/WB; GST
Matthew EM , et al. 2010
PPFIA2 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 8499 O75334 Y2H
Sakai Y , et al. 2011
RALYL RALY RNA binding protein-like 138046 Q86SE5 Y2H
Sakai Y , et al. 2011
RB1CC1 RB1-inducible coiled-coil 1 9821 Q8TDY2 Y2H; GST; IP/WB
Gan B , et al. 2005
RHEB Ras homolog enriched in brain 6009 Q15382 GTP hydrolysis assay
Garami A , et al. 2003
RICTOR RPTOR independent companion of MTOR, complex 2 253260 Q6R327 IP/WB
Huang J , et al. 2009
RPS6KA1 ribosomal protein S6 kinase, 90kDa, polypeptide 1 6195 Q15418 IP/WB
Roux PP , et al. 2004
RUNDC3A RUN domain containing 3A 10900 Q59EK9 Y2H
Sakai Y , et al. 2011
SCMH1 sex comb on midleg homolog 1 (Drosophila) 22955 Q96GD3 Y2H
Sakai Y , et al. 2011
SEC31A SEC31 homolog A (S. cerevisiae) 22872 O94979 Y2H
Sakai Y , et al. 2011
SEPW1 selenoprotein W, 1 6415 P63302 Y2H
Sakai Y , et al. 2011
SERTAD1 SERTA domain containing 1 29950 Q9UHV2 Y2H
Sakai Y , et al. 2011
SHANK1 SH3 and multiple ankyrin repeat domains 1 50944 Q9Y566 Y2H; IP/WB
Sakai Y , et al. 2011
SORBS3 sorbin and SH3 domain containing 3 10174 O60504 Y2H
Sakai Y , et al. 2011
SPAG5 sperm associated antigen 5 10615 Q96R06 Y2H
Sakai Y , et al. 2011
TANK TRAF family member-associated NFKB activator 10010 Q92844 Y2H; GST
Sakai Y , et al. 2011
TBC1D7 TBC1 domain family, member 7 51256 Q9P0N9 IP/WB; GST
Nakashima A , et al. 2007
TBC1D7 TBC1 domain family, member 7 51256 Q9P0N9 IP; LC-MS/MS
Huttlin EL , et al. 2015
TFIP11 tuftelin interacting protein 11 24144 Q9UBB9 Y2H
Sakai Y , et al. 2011
TRIM3 tripartite motif containing 3 10612 O75382 Y2H
Sakai Y , et al. 2011
TRIOBP TRIO and F-actin binding protein 11078 Q9H2D6 Y2H
Sakai Y , et al. 2011
TSC1 tuberous sclerosis 1 7248 Q92574 Y2H
Nellist M , et al. 1999
TSC2 tuberous sclerosis 2 7249 P49815 Y2H; IP/WB
van Slegtenhorst M , et al. 1998
UBC ubiquitin C 7316 P63279 IP/WB
Benvenuto G , et al. 2001
VIM vimentin 7431 P08670 Y2H
Sakai Y , et al. 2011
YWHAB tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide 7529 P31946 GST
Nellist M , et al. 2002
YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide 7531 P62258 GST
Nellist M , et al. 2002
YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide 7532 P61981 GST
Nellist M , et al. 2002
YWHAH tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide 7533 Q04917 GST
Nellist M , et al. 2002
YWHAQ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide 10971 P27348 GST
Nellist M , et al. 2002
YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide 7534 P63104 GST
Nellist M , et al. 2002
ZNF423 zinc finger protein 423 23090 Q2M1K9 Y2H
Sakai Y , et al. 2011
Msn moesin 17698 P26041 Y2H; GST
Lamb RF , et al. 2000
Rdx radixin 19684 P26043 Y2H; GST
Lamb RF , et al. 2000
Shank3 SH3/ankyrin domain gene 3 58234 Q4ACU6 IP/WB
Sakai Y , et al. 2011
STAT3 signal transducer and activator of transcription 3 20848 P42227 qRT-PCR; ELISA; IP/WB
Xu Y , et al. 2015
MYCBP2 MYC binding protein 2 23077 O75592 IP/WB
Murthy V , et al. 2003
Ppp1r15a protein phosphatase 1, regulatory subunit 15A 171071 Q6IN02 IP/WB
Hyrskyluoto A , et al. 2011
PTK2 PTK2 protein tyrosine kinase 2 5747 Q05397 GST
Gan B , et al. 2006
unk unkempt 42738 Q86B79 Immunofluorescence; M2 affinity gel assay; IP/WB
Avet-Rochex A , et al. 2014

HELP
Copyright © 2017 MindSpec, Inc.